<p>(A) Representative flow histograms depicting cell cycle distribution in wild-type HCT-116 cells (WT) and PUMA knockout HCT-116 cells (PUMA KO) after 24 h treatment with DMSO or 5 µM BITC. Quantitation of (B) sub-G0/G1 and (C) G2/M fraction in WT and PUMA KO HCT-116 cells after 24 h treatment with DMSO or 5 µM BITC. The experiment was repeated twice and merged data from both the experiments are shown. Data represent mean ± SD (n = 4). <sup>a</sup>Significantly different (P<0.05) compared with DMSO-treated control by one-way ANOVA followed by Bonferroni's multiple comparison test. (D) Immunoblotting for p21 and cdk1 using lysates from WT and PUMA KO HCT-116 cells treated for 24 h with DMSO or the indicated concentrations of BITC. Each expe...
<p><b>A</b> Cell cycle analysis of U87MG cells was performed 24 h, 48 h and 72 h after CAP treatment...
<p>(<b>A–D</b>) BV173 and K562 cells were treated with the indicated concentration of HP-β-CyD for 1...
<p><b>A.</b> Left panel: Structure of bDHC. Right panel: Dose-response effect of bDHC on cell viabil...
<p>(A) Immunoblotting for PUMA protein using lysates from wild-type HCT-116 cells (WT) and PUMA knoc...
<p>(A) Western blotting for Bcl-xL and Bcl-2 using lysates from MDA-MB-231 cells treated with DMSO (...
<p>(A) The cell cycle phases of DBP5, GLE1 and IPPK knocked-down cells were investigated by flow cyt...
HT-29 cells were pretreated with 500 μM BSO for 24 h and then the cells were treated with 10 μM DATS...
<p>U2OS cells were transfected with p16, p16-ACT, p14ARF, chARF, GFP, or no DNA (mock). 24 hours aft...
<p>(A) Cell cycle analysis of HT-29 cells treated with resibufogenin. Cells were treated with resibu...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
Distribution of A2780 and A2780cis cells in G1, S, and G2/M phases of the cell cycle after 5 mM NaBu...
<p>(<b>A</b>) Histograms depict cell cycle distributions in MCF-10A, MDA-MB-231 and MCF-7 cells afte...
<p>(A) The cell cycle distribution of Huh7 cells that were treated with various doses of ICD for 18 ...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>Cells were serum-starved for 24 hours in order to synchronize cells at the G0/G1 stage. Cells wer...
<p><b>A</b> Cell cycle analysis of U87MG cells was performed 24 h, 48 h and 72 h after CAP treatment...
<p>(<b>A–D</b>) BV173 and K562 cells were treated with the indicated concentration of HP-β-CyD for 1...
<p><b>A.</b> Left panel: Structure of bDHC. Right panel: Dose-response effect of bDHC on cell viabil...
<p>(A) Immunoblotting for PUMA protein using lysates from wild-type HCT-116 cells (WT) and PUMA knoc...
<p>(A) Western blotting for Bcl-xL and Bcl-2 using lysates from MDA-MB-231 cells treated with DMSO (...
<p>(A) The cell cycle phases of DBP5, GLE1 and IPPK knocked-down cells were investigated by flow cyt...
HT-29 cells were pretreated with 500 μM BSO for 24 h and then the cells were treated with 10 μM DATS...
<p>U2OS cells were transfected with p16, p16-ACT, p14ARF, chARF, GFP, or no DNA (mock). 24 hours aft...
<p>(A) Cell cycle analysis of HT-29 cells treated with resibufogenin. Cells were treated with resibu...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
Distribution of A2780 and A2780cis cells in G1, S, and G2/M phases of the cell cycle after 5 mM NaBu...
<p>(<b>A</b>) Histograms depict cell cycle distributions in MCF-10A, MDA-MB-231 and MCF-7 cells afte...
<p>(A) The cell cycle distribution of Huh7 cells that were treated with various doses of ICD for 18 ...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>Cells were serum-starved for 24 hours in order to synchronize cells at the G0/G1 stage. Cells wer...
<p><b>A</b> Cell cycle analysis of U87MG cells was performed 24 h, 48 h and 72 h after CAP treatment...
<p>(<b>A–D</b>) BV173 and K562 cells were treated with the indicated concentration of HP-β-CyD for 1...
<p><b>A.</b> Left panel: Structure of bDHC. Right panel: Dose-response effect of bDHC on cell viabil...